Market validation, commercial and regulatory Pathways

This service entails developing strategies for entering new geographical markets, including regulatory, cultural, and market dynamics. We specialise in helping organisations enter and expand into new geographical markets, navigating regulatory, cultural, and market dynamics. We go beyond traditional consulting by collaborating with founders to refine their business and technology strategy. Whether crafting a go-to-market plan, securing funding, or building a scalable tech architecture, we provide actionable insights and direct support. By leveraging our extensive startup experience, we help founders avoid common pitfalls and position their companies for long-term success in the competitive landscape. This is further leveraged by our vast experience supporting the market access of multiple lines of products in the Life Science and MedTech sectors. This service includes: a) Qualified commercial introductions: Curated matchmaking with pharmaceutical and MedTech firms, health clinics, pharmacy chains, and other key stakeholders, which includes prior due diligence on the clients. b) Market validation: designed to help startups understand and quantify the potential of relevant European markets. Our comprehensive approach delivers in-depth analysis and validation by directly engaging a network of local experts and healthcare professionals. 

The primary goal of this service is to secure direct market validation of the product or service from healthcare professionals and decision-makers in the target country, to facilitate market adoption and ensure the conditions for reimbursement and/or commercialisation are being met:- Startups receive personalised support tailored to their specific needs, with a diverse range of service components, including: 

i) Market Positioning – Segmentation, targeting, and competitive differentiation. 

ii) Business Model Validation – Pricing, reimbursement pathways, and revenue streams. 

iii) Operational Roadmap – Resource allocation, risk mitigation, and milestone tracking. 

iv) Refinement of the value proposition using the language, concepts, and priorities of local payers and decision-makers. 

v) Quantification of market opportunity through access to local data interpreted by expert analysts. 

The service is primarily delivered online, with the option of a hybrid format if required. EU key regions include the CEE region, including Romania, the UK, Spain, Belgium, France, Germany, Italy, the Netherlands, Portugal, Switzerland, and the UK.